Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Cyclophilin A as a biomarker for the therapeutic effect of balloon angioplasty in chronic thromboembolic pulmonary hypertension.

Kozu K, Satoh K, Aoki T, Tatebe S, Miura M, Yamamoto S, Yaoita N, Suzuki H, Shimizu T, Sato H, Konno R, Terui Y, Nochioka K, Kikuchi N, Satoh T, Sugimura K, Miyata S, Shimokawa H.

J Cardiol. 2019 Oct 12. pii: S0914-5087(19)30300-4. doi: 10.1016/j.jjcc.2019.09.010. [Epub ahead of print]

PMID:
31615744
2.

Engineering the expression system for Komagataella phaffii (Pichia pastoris): an attempt to develop a methanol-free expression system.

Takagi S, Tsutsumi N, Terui Y, Kong X, Yurimoto H, Sakai Y.

FEMS Yeast Res. 2019 Sep 1;19(6). pii: foz059. doi: 10.1093/femsyr/foz059.

3.

Successful Management of Acute Congestive Heart Failure by Emergent Caesarean Section Followed by Adrenalectomy in a Pregnant Woman with Cushing's Syndrome-induced Cardiomyopathy.

Sakota M, Tatebe S, Sugimura K, Aoki T, Yamamoto S, Sato H, Kikuchi N, Konno R, Terui Y, Satoh K, Tezuka Y, Morimoto R, Saito M, Kuniyoshi S, Shimokawa H.

Intern Med. 2019 Oct 1;58(19):2819-2824. doi: 10.2169/internalmedicine.2427-18. Epub 2019 Jun 27.

4.

Inhibition of dendritic spine extension through acrolein conjugation with α-, β-tubulin proteins.

Uemura T, Suzuki T, Ko K, Watanabe K, Dohmae N, Sakamoto A, Terui Y, Toida T, Kashiwagi K, Igarashi K.

Int J Biochem Cell Biol. 2019 Aug;113:58-66. doi: 10.1016/j.biocel.2019.05.016. Epub 2019 May 28.

PMID:
31150838
5.

Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2).

Yokoyama M, Kusano Y, Nishihara A, Inoue N, Nishimura N, Mishima Y, Terui Y, Nukada T, Nomura T, Hatake K.

Support Care Cancer. 2019 May 15. doi: 10.1007/s00520-019-04802-4. [Epub ahead of print]

PMID:
31093770
6.

New evaluation of trunk movement and balance during walking in COPD patients by a triaxial accelerometer.

Terui Y, Iwakura M, Suto E, Kawagoshi A, Sugawara K, Takahashi H, Hasegawa K, Uemura S, Satake M, Shioya T.

Int J Chron Obstruct Pulmon Dis. 2018 Dec 7;13:3957-3962. doi: 10.2147/COPD.S184212. eCollection 2018.

7.

Villous colonization (glove balloon sign): A histopathological diagnostic marker for follicular lymphomas with duodenal involvement including duodenal-type follicular lymphoma.

Tsuyama N, Yokoyama M, Fujisaki J, Oguchi M, Terui Y, Takeuchi K.

Pathol Int. 2019 Jan;69(1):48-50. doi: 10.1111/pin.12740. Epub 2018 Dec 24. No abstract available.

PMID:
30582768
8.

Effects of Hepatitis C Virus Antibody-Positivity on Cardiac Function and Long-Term Prognosis in Patients With Adult Congenital Heart Disease.

Konno R, Tatebe S, Sugimura K, Satoh K, Aoki T, Miura M, Yamamoto S, Sato H, Kozu K, Terui Y, Miyata S, Adachi O, Kimura M, Saiki Y, Shimokawa H.

Am J Cardiol. 2018 Dec 1;122(11):1965-1971. doi: 10.1016/j.amjcard.2018.08.045. Epub 2018 Sep 8.

PMID:
30442226
9.

HIV positivity may not have a negative impact on survival in Epstein-Barr virus-positive Hodgkin lymphoma: A Japanese nationwide retrospective survey.

Yotsumoto M, Ito Y, Hagiwara S, Terui Y, Nagai H, Ota Y, Ajisawa A, Uehira T, Tanuma J, Ohyashiki K, Okada S.

Oncol Lett. 2018 Sep;16(3):3923-3928. doi: 10.3892/ol.2018.9132. Epub 2018 Jul 11.

10.

Ambient fine and coarse particles in Japan affect nasal and bronchial epithelial cells differently and elicit varying immune response.

Onishi T, Honda A, Tanaka M, Chowdhury PH, Okano H, Okuda T, Shishido D, Terui Y, Hasegawa S, Kameda T, Tohno S, Hayashi M, Nishita-Hara C, Hara K, Inoue K, Yasuda M, Hirano S, Takano H.

Environ Pollut. 2018 Nov;242(Pt B):1693-1701. doi: 10.1016/j.envpol.2018.07.103. Epub 2018 Jul 27.

PMID:
30086990
11.

Improvement of physical activity in chronic obstructive pulmonary disease by pulmonary rehabilitation and pharmacological treatment.

Shioya T, Sato S, Iwakura M, Takahashi H, Terui Y, Uemura S, Satake M.

Respir Investig. 2018 Jul;56(4):292-306. doi: 10.1016/j.resinv.2018.05.002. Epub 2018 Jun 11. Review.

PMID:
29903607
12.

Protective Effects of Brain Infarction by N-Acetylcysteine Derivatives.

Uemura T, Watanabe K, Ko K, Higashi K, Kogure N, Kitajima M, Takayama H, Takao K, Sugita Y, Sakamoto A, Terui Y, Toida T, Kashiwagi K, Igarashi K.

Stroke. 2018 Jul;49(7):1727-1733. doi: 10.1161/STROKEAHA.118.021755. Epub 2018 Jun 4.

PMID:
29866754
13.

Polyamines protect nucleic acids against depurination.

Terui Y, Yoshida T, Sakamoto A, Saito D, Oshima T, Kawazoe M, Yokoyama S, Igarashi K, Kashiwagi K.

Int J Biochem Cell Biol. 2018 Jun;99:147-153. doi: 10.1016/j.biocel.2018.04.008. Epub 2018 Apr 9.

PMID:
29649565
14.

Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.

Yamaguchi M, Suzuki R, Kim SJ, Ko YH, Oguchi M, Asano N, Miyazaki K, Terui Y, Kubota N, Maeda T, Kobayashi Y, Amaki J, Soejima T, Saito B, Shimoda E, Fukuhara N, Tsukamoto N, Shimada K, Choi I, Utsumi T, Ejima Y, Kim WS, Katayama N.

Cancer Sci. 2018 Jun;109(6):2056-2062. doi: 10.1111/cas.13597. Epub 2018 Apr 28.

15.

Evaluation of gait symmetry using a tri-axial accelerometer in stroke patients.

Terui Y, Suto E, Konno Y, Kubota K, Iwakura M, Satou M, Nitta S, Hasegawa K, Satake M, Shioya T.

NeuroRehabilitation. 2018;42(2):173-180. doi: 10.3233/NRE-172235.

PMID:
29562555
16.

[Lenalidomide and low-dose dexamethasone therapy for Japanese patients with newly diagnosed multiple myeloma: updated results of the MM-025 study].

Ando K, Chou T, Suzuki K, Shinagawa A, Uchida T, Taniwaki M, Hirata H, Ishizawa K, Matsue K, Okamoto S, Otsuka M, Matsumoto M, Iida S, Matsumura I, Ikeda T, Takezako N, Ogaki Y, Midorikawa S, Houck V, Ervin-Haynes A, Terui Y.

Rinsho Ketsueki. 2017;58(11):2219-2226. doi: 10.11406/rinketsu.58.2219. Japanese.

PMID:
29212972
17.

Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance.

Kusano Y, Yokoyama M, Inoue N, Yamauchi H, Takahashi A, Tsuyama N, Mishima Y, Nishimura N, Takeuchi K, Terui Y, Hatake K.

Ann Hematol. 2018 Feb;97(2):289-297. doi: 10.1007/s00277-017-3175-7. Epub 2017 Nov 14.

PMID:
29138885
18.

Modulation of Protein Synthesis by Polyamines in Mammalian Cells.

Kashiwagi K, Terui Y, Igarashi K.

Methods Mol Biol. 2018;1694:325-336. doi: 10.1007/978-1-4939-7398-9_27.

PMID:
29080177
19.

Bearing 19q13 aberration predicts poor prognosis in non-germinal centre type of CD5+ DLBCL.

Mishima Y, Terui Y, Yokoyama M, Nishimura N, Ueda K, Kusano Y, Yamauchi H, Inoue N, Takahashi A, Tsuyama N, Mishima Y, Takeuchi K, Hatake K.

Br J Haematol. 2018 Nov;183(4):661-664. doi: 10.1111/bjh.15001. Epub 2017 Oct 26. No abstract available.

PMID:
29076146
20.

Sudden failure of ventricular pacing and recovery in a patient with cardiac sarcoidosis.

Terui Y, Nakamura A, Endo H, Kadosaka T, Nakata T, Watanabe T, Sato K, Kanazawa M, Kondo M, Takahashi T, Nozaki E.

J Arrhythm. 2017 Oct;33(5):521-522. doi: 10.1016/j.joa.2017.06.004. Epub 2017 Jul 26.

21.

High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy.

Kusano Y, Yokoyama M, Terui Y, Inoue N, Takahashi A, Yamauchi H, Tsuyama N, Nishimura N, Mishima Y, Takeuchi K, Hatake K.

Blood Cancer J. 2017 Sep 29;7(9):e614. doi: 10.1038/bcj.2017.96. No abstract available.

22.

Combination therapy with monoclonal antibodies for treatment of newly diagnosed multiple myeloma.

Nishimura N, Terui Y, Hatake K.

Rinsho Ketsueki. 2017;58(8):1006-1013. doi: 10.11406/rinketsu.58.1006. Japanese.

PMID:
28883263
23.

Focused assessment with sonography for trauma (FAST) identifies liver injury following cardiopulmonary resuscitation.

Nashiki H, Miyate Y, Terui Y, Otani M.

BMJ Case Rep. 2017 Jul 19;2017. pii: bcr-2017-221421. doi: 10.1136/bcr-2017-221421.

24.

Efficacy of chemotherapy in extremely elderly patients with diffuse large B-cell lymphoma.

Takahashi A, Mishima Y, Yokoyama M, Inoue N, Kusano Y, Gunji T, Nitta H, Ueda K, Nishimura N, Tsuyama N, Takeuchi K, Terui Y, Hatake K.

Rinsho Ketsueki. 2017;58(5):427-432. doi: 10.11406/rinketsu.58.427. Japanese.

PMID:
28592754
25.

Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan.

Yokoyama M, Kusano Y, Takahashi A, Inoue N, Ueda K, Nishimura N, Mishima Y, Terui Y, Nukada T, Nomura T, Hatake K.

Support Care Cancer. 2017 Nov;25(11):3313-3320. doi: 10.1007/s00520-017-3747-z. Epub 2017 May 27.

26.

BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.

Tsuyama N, Sakata S, Baba S, Mishima Y, Nishimura N, Ueda K, Yokoyama M, Terui Y, Hatake K, Kitagawa M, Ishizuka N, Tomita N, Takeuchi K.

Blood. 2017 Jul 27;130(4):489-500. doi: 10.1182/blood-2016-12-759621. Epub 2017 May 18.

PMID:
28522442
27.

Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.

Mishima Y, Matsusaka S, Chin K, Mikuniya M, Minowa S, Takayama T, Shibata H, Kuniyoshi R, Ogura M, Terui Y, Mizunuma N, Hatake K.

Target Oncol. 2017 Jun;12(3):341-351. doi: 10.1007/s11523-017-0493-6.

PMID:
28508152
28.

Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma.

Kusano Y, Yokoyama M, Terui Y, Nishimura N, Mishima Y, Ueda K, Tsuyama N, Yamauchi H, Takahashi A, Inoue N, Takeuchi K, Hatake K.

Blood Cancer J. 2017 May 12;7(5):e561. doi: 10.1038/bcj.2017.43. No abstract available.

29.

Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma.

Kusano Y, Yokoyama M, Terui Y, Nishimura N, Mishima Y, Ueda K, Tsuyama N, Yamauchi H, Takahashi A, Inoue N, Takeuchi K, Hatake K.

Blood Cancer J. 2017 Apr 21;7(4):e558. doi: 10.1038/bcj.2017.37. Erratum in: Blood Cancer J. 2017 May 12;7(5):e561.

30.

Comparison of the measured pre-ejection periods and left ventricular ejection times between echocardiography and impedance cardiography for optimizing cardiac resynchronization therapy.

Noda K, Endo H, Kadosaka T, Nakata T, Watanabe T, Terui Y, Kajitani S, Monnma Y, Sato K, Kanazawa M, Nakajima S, Kondo M, Takahashi T, Nakamura A, Nozaki E.

J Arrhythm. 2017 Apr;33(2):130-133. doi: 10.1016/j.joa.2016.08.003. Epub 2016 Sep 12.

31.

Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.

Tsuyama N, Ennishi D, Yokoyama M, Baba S, Asaka R, Mishima Y, Terui Y, Hatake K, Takeuchi K.

Oncotarget. 2017 May 16;8(20):33487-33500. doi: 10.18632/oncotarget.16532.

32.

Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma.

Maruyama D, Hatake K, Kinoshita T, Fukuhara N, Choi I, Taniwaki M, Ando K, Terui Y, Higuchi Y, Onishi Y, Abe Y, Kobayashi T, Shirasugi Y, Tobinai K.

Cancer Sci. 2017 May;108(5):1007-1012. doi: 10.1111/cas.13230. Epub 2017 May 19.

33.

Long-term follow-up results of a phase I/II study of melphalan, prednisolone and bortezomib in Japanese transplant-ineligible multiple myeloma patients (JPN-102).

Ogiya D, Shibayama H, Nakatani E, Ando K, Suzuki K, Kuroda Y, Uchida T, Maruyama D, Matsumoto M, Matsue K, Iida S, Terui Y, Ri M, Chou T, Aotsuka N, Tabata S, Konishi J, Ohashi K, Shinagawa A, Sugiura I, Kuroda J, Miyamoto T, Ogura M, Tobinai K, Kanakura Y, Hotta T.

Rinsho Ketsueki. 2016;57(11):2311-2318. Japanese.

PMID:
27941278
34.

Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan.

Ogura M, Ishizawa K, Maruyama D, Uike N, Ando K, Izutsu K, Terui Y, Imaizumi Y, Tsukasaki K, Suzuki K, Izumi T, Usuki K, Kinoshita T, Taniwaki M, Uoshima N, Suzumiya J, Kurosawa M, Nagai H, Uchida T, Fukuhara N, Choi I, Ohmachi K, Yamamoto G, Tobinai K; Japanese Bendamustine Lymphoma Study Group.

Int J Hematol. 2017 Apr;105(4):470-477. doi: 10.1007/s12185-016-2146-4. Epub 2016 Nov 29.

PMID:
27900638
35.

Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional Translocation.

Shigematsu Y, Matsuura M, Nishimura N, Tsuyama N, Takeuchi K, Terui Y, Takeshima N, Hatake K.

Intern Med. 2016;55(21):3169-3174. Epub 2016 Nov 1.

36.

Polyamines release the let-7b-mediated suppression of initiation codon recognition during the protein synthesis of EXT2.

Imamura M, Higashi K, Yamaguchi K, Asakura K, Furihata T, Terui Y, Satake T, Maegawa J, Yasumura K, Ibuki A, Akase T, Nishimura K, Kashiwagi K, Linhardt RJ, Igarashi K, Toida T.

Sci Rep. 2016 Sep 21;6:33549. doi: 10.1038/srep33549.

37.

Decrease in acrolein toxicity based on the decline of polyamine oxidases.

Uemura T, Nakamura M, Sakamoto A, Suzuki T, Dohmae N, Terui Y, Tomitori H, Casero RA Jr, Kashiwagi K, Igarashi K.

Int J Biochem Cell Biol. 2016 Oct;79:151-157. doi: 10.1016/j.biocel.2016.08.039. Epub 2016 Aug 30.

PMID:
27590852
38.

Effect of Spermidine Analogues on Cell Growth of Escherichia coli Polyamine Requiring Mutant MA261.

Yoshida T, Sakamoto A, Terui Y, Takao K, Sugita Y, Yamamoto K, Ishihama A, Igarashi K, Kashiwagi K.

PLoS One. 2016 Jul 19;11(7):e0159494. doi: 10.1371/journal.pone.0159494. eCollection 2016.

39.

Epstein-Barr virus gastric ulcer associated with ruxolitinib.

Kusano Y, Terui Y, Ueda K, Hatake K.

Ann Hematol. 2016 Oct;95(10):1741-2. doi: 10.1007/s00277-016-2748-1. Epub 2016 Jul 14. No abstract available.

40.

Lichenoid drug eruption associated with Bendamustine.

Kusano Y, Terui Y, Yokoyama M, Hatake K.

Blood Cancer J. 2016 Jun 24;6(6):e438. doi: 10.1038/bcj.2016.48. No abstract available.

41.

Klebsiella pneumoniae primary liver abscess associated with ruxolitinib.

Kusano Y, Terui Y, Ueda K, Hatake K.

Ann Hematol. 2016 Sep;95(9):1561-2. doi: 10.1007/s00277-016-2718-7. Epub 2016 Jun 4. No abstract available.

42.

Myelomatous meningitis: a case report.

Kusano Y, Terui Y, Nishimura N, Yokoyama M, Ueda K, Hatake K.

Int J Hematol. 2016 Aug;104(2):149-50. doi: 10.1007/s12185-016-2024-0. Epub 2016 May 27. No abstract available.

PMID:
27233510
43.

Poly-ion Complex of Chondroitin Sulfate and Spermine and Its Effect on Oral Chondroitin Sulfate Bioavailability.

Ge D, Higashi K, Ito D, Nagano K, Ishikawa R, Terui Y, Higashi K, Moribe K, Linhardt RJ, Toida T.

Chem Pharm Bull (Tokyo). 2016;64(5):390-8. doi: 10.1248/cpb.c15-00940.

44.

Radiation therapy for localized duodenal low-grade follicular lymphoma.

Harada A, Oguchi M, Terui Y, Takeuchi K, Igarashi M, Kozuka T, Harada K, Uno T, Hatake K.

J Radiat Res. 2016 Jul;57(4):412-7. doi: 10.1093/jrr/rrw011. Epub 2016 Mar 23.

45.

Increasing Incidence of Tuberculosis Infection in the Coastal Region of Northern Miyagi after the Great East Japan Earthquake.

Sakurai M, Takahashi T, Ohuchi M, Terui Y, Kiryu K, Shikano K.

Tohoku J Exp Med. 2016 Mar;238(3):187-95. doi: 10.1620/tjem.238.187.

46.

Lenalidomide and low-dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study.

Suzuki K, Shinagawa A, Uchida T, Taniwaki M, Hirata H, Ishizawa K, Matsue K, Ogawa Y, Shimizu T, Otsuka M, Matsumoto M, Iida S, Terui Y, Matsumura I, Ikeda T, Takezako N, Ogaki Y, Midorikawa S, Houck V, Ervin-Haynes A, Chou T.

Cancer Sci. 2016 May;107(5):653-8. doi: 10.1111/cas.12916. Epub 2016 Mar 30.

47.

Gastric involvement, a rare site for extramedullary myeloma.

Kusano Y, Nishimura N, Yokoyama M, Terui Y, Hatake K.

Ann Hematol. 2016 Mar;95(4):663-4. doi: 10.1007/s00277-016-2596-z. Epub 2016 Jan 12. No abstract available.

PMID:
26754637
48.

Effects of polyamines from Thermus thermophilus, an extreme-thermophilic eubacterium, on tRNA methylation by tRNA (Gm18) methyltransferase (TrmH).

Hori H, Terui Y, Nakamoto C, Iwashita C, Ochi A, Watanabe K, Oshima T.

J Biochem. 2016 May;159(5):509-17. doi: 10.1093/jb/mvv130. Epub 2015 Dec 31.

PMID:
26721905
49.

Toxic acrolein production due to Ca(2+) influx by the NMDA receptor during stroke.

Nakamura M, Uemura T, Saiki R, Sakamoto A, Park H, Nishimura K, Terui Y, Toida T, Kashiwagi K, Igarashi K.

Atherosclerosis. 2016 Jan;244:131-7. doi: 10.1016/j.atherosclerosis.2015.11.012. Epub 2015 Nov 14.

PMID:
26630182
50.

Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies.

Ogura M, Uchida T, Terui Y, Hayakawa F, Kobayashi Y, Taniwaki M, Takamatsu Y, Naoe T, Tobinai K, Munakata W, Yamauchi T, Kageyama A, Yuasa M, Motoyama M, Tsunoda T, Hatake K.

Cancer Sci. 2015 Jul;106(7):896-901. doi: 10.1111/cas.12683. Epub 2015 May 25.

Supplemental Content

Support Center